Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction. Stringent regulatory policies in the European Union is likely to restrain market growth. Patent expiry of biological drugs creates new growth opportunities for key API manufacturers.
The report segments the market on the basis of synthesis, type of manufacturer, type and therapy. Based on synthesis, this market is segmented into synthetic API and biotech API. The former is further segmented into Innovative synthetic APIS and generic synthetic APIS, while the latter is further segmented on the basis of products and type. The biotech APIS market, by product is further segmented into monoclonal antibodies, recombinant proteins and vaccines. On the basis of type of manufacturer, this market is segmented into captive API manufacturers, merchant API manufacturers, innovative APIS and generic APIS. On the basis of type, the market is segmented into innovative APIS segment and generic APIS segment. On the basis of therapy, the market is segmented into oncology, diabetes, cardiovascular disease, Cns and neurological disorders, orthopedic disorders, nephrology, ophthalmology, pulmonology, gastrointestinal disorders and endocrinology.
On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).
Key market players in this market are Teva Pharmaceutical Industries Limited, Dr. Reddys Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Novartis International AG, Albemarle Corporation, Sigma-Aldrich Corporation, Mylan Inc., and Allergan PLC
KEY BENEFITS FOR STAKEHOLDERS:
SIMILAR MARKET STUDIES
Summary AxiCorp GmbH (AxiCorp) is a manufacturer and distributor of EU pharmaceuticals and generics. The company operates through two divisions, namely, PI pharmaceuticals and self-medication. AxiCorp’s self-medication sector includes health products related to non-prescription drugs. The company offers OTC medicines, medical products, cosmetics or nutritional supplements. It offers ibutop pain relieving ...
July 2014 | $250 | View Details >>
Summary Avacta Group Plc (Avacta) is a healthcare company that offers technology services. The company provides innovative and proprietary solutions to the life sciences and healthcare sector. It operates with Avacta analytical, Avacta animal health, Avacta life sciences and Animal allergy divisions. Avacta offers products such as Optim and Sensipod through ...
March 2016 | $250 | View Details >>
This report studies the Dental X-ray System market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Dental X-ray System market by product type and applicationsend industries. The ...
March 2017 | $3268 | View Details >>
Summary Athera Biotechnologies AB (Athera) is a biopharmaceutical company. It develops targeted anti inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease. The company has a proprietary pre IND program, PC-mAb, supported by an approved proprietary companion diagnostic kit. Atheras product includes PC-mAb, which is ...
July 2015 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research